BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22480224)

  • 1. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
    Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
    J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the Pap test? Awareness and use of the Pap test among women in the United States.
    Hawkins NA; Cooper CP; Saraiya M; Gelb CA; Polonec L
    J Womens Health (Larchmt); 2011 Apr; 20(4):511-5. PubMed ID: 21443450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confusion about Pap smears: lack of knowledge among high-risk women.
    Daley E; Perrin K; Vamos C; Hernandez N; Anstey E; Baker E; Kolar S; Ebbert J
    J Womens Health (Larchmt); 2013 Jan; 22(1):67-74. PubMed ID: 23215902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
    Johnson NL; Head KJ; Scott SF; Zimet GD
    Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
    Eltoum IA; Roberson J
    Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening among young adult women in the United States.
    Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Watson M; Benard V; King J; Crawford A; Saraiya M
    Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Cardiovascular Disease on Compliance with Cervical and Breast Cancer Screening Recommendations Among Adult Women.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2015 Aug; 24(8):641-7. PubMed ID: 26263281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened.
    Chen HY; Kessler CL; Mori N; Chauhan SP
    J Womens Health (Larchmt); 2012 Nov; 21(11):1132-8. PubMed ID: 22873781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
    Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
    Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
    Hewitt M; Devesa SS; Breen N
    Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.